跳至主要内容
临床试验/NCT00490191
NCT00490191已完成4 期

Comparison of an Incremental Weight-Based Dose Regimen With an Individualized Dosage Adjusted According to the IGF-I Response in Adults With Growth Hormone Deficiency

Eli Lilly and Company26 个研究点 分布在 6 个国家目标入组 387 人开始时间: 1999年1月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
387
试验地点
26
主要终点
Percent change in total fat mass

研究概览

简要总结

This study tested whether a dose regimen of growth hormone based on body weight is equivalent or better than starting with a low dose and gradually increasing the dose according to individual patient needs. Efficacy of the two regimens were assessed from changes in body fat measured by dual-energy x-ray absorptiometry (DXA) scanning, performed at the beginning of the study and at the completion of the study eight months later.

详细描述

Dose regimen of growth hormone based on weight: Starting dose was 4.0 micrograms/kg/day for four months, then increased to 8 micrograms/kg/day for two months, and then increased to 12 micrograms/kg/day for a further two months (eight months in total).

Dose regimen of growth hormone based on individual patient needs: Starting dose was 200 micrograms/day, then increased by 200 micrograms/day every two months for an additional six months (eight months in total) as needed for optimal treatment results.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have growth hormone deficiency that started in childhood or adulthood
  • Have not received any growth hormone treatment in the last 12 months
  • Have had a growth hormone stimulation test within the last two years showing abnormally low response
  • Have received adequate and stable hormonal replacement for other hormone deficiencies during the last three months

排除标准

  • Presence of clinically significant diseases, such as cancer, lung, heart, liver, kidney, neuromuscular, genetic, or severe psychiatric diseases
  • Recent growth of pituitary tumor or other intracranial tumor
  • History of acromegaly
  • Taking medication to suppress appetite or reduce weight, or antidepressant drugs
  • Poorly-controlled high blood pressure or diabetes

结局指标

主要结局

Percent change in total fat mass

时间窗: Eight months

次要结局

  • Safety(Eight months)

研究者

申办方类型
Industry

研究点 (26)

Loading locations...

相似试验